243 related articles for article (PubMed ID: 31504978)
1. Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature.
Fragoulis GE; Conway R; Nikiphorou E
Rheumatology (Oxford); 2019 Nov; 58(11):1900-1906. PubMed ID: 31504978
[TBL] [Abstract][Full Text] [Related]
2. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Roubille C; Haraoui B
Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and rheumatoid arthritis associated interstitial lung disease.
Juge PA; Lee JS; Lau J; Kawano-Dourado L; Rojas Serrano J; Sebastiani M; Koduri G; Matteson E; Bonfiglioli K; Sawamura M; Kairalla R; Cavagna L; Bozzalla Cassione E; Manfredi A; Mejia M; Rodríguez-Henriquez P; González-Pérez MI; Falfán-Valencia R; Buendia-Roldán I; Pérez-Rubio G; Ebstein E; Gazal S; Borie R; Ottaviani S; Kannengiesser C; Wallaert B; Uzunhan Y; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Wemeau-Stervinou L; Flipo RM; Marchand-Adam S; Richette P; Allanore Y; Dromer C; Truchetet ME; Richez C; Schaeverbeke T; Lioté H; Thabut G; Deane KD; Solomon JJ; Doyle T; Ryu JH; Rosas I; Holers VM; Boileau C; Debray MP; Porcher R; Schwartz DA; Vassallo R; Crestani B; Dieudé P
Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32646919
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.
Fragoulis GE; Nikiphorou E; Larsen J; Korsten P; Conway R
Front Med (Lausanne); 2019; 6():238. PubMed ID: 31709258
[TBL] [Abstract][Full Text] [Related]
6. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study.
Ibfelt EH; Jacobsen RK; Kopp TI; Cordtz RL; Jakobsen AS; Seersholm N; Shaker SB; Dreyer L
Rheumatology (Oxford); 2021 Jan; 60(1):346-352. PubMed ID: 32780828
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy.
Suwa A; Hirakata M; Satoh S; Mimori T; Utsumi K; Inada S
Clin Exp Rheumatol; 1999; 17(3):355-8. PubMed ID: 10410272
[TBL] [Abstract][Full Text] [Related]
9. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid arthritis and lung - more than a minor aspect of the disease].
Fiehn C
Dtsch Med Wochenschr; 2015 Jun; 140(12):904-7. PubMed ID: 26069917
[TBL] [Abstract][Full Text] [Related]
11. [Two fatal cases of methotrexate-induced interstitial pneumonitis].
Matsushima H; Takayanagi N; Kawata I; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
Nihon Kokyuki Gakkai Zasshi; 2002 Mar; 40(3):249-55. PubMed ID: 11974902
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
[TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonitis associated with infliximab therapy.
Villeneuve E; St-Pierre A; Haraoui B
J Rheumatol; 2006 Jun; 33(6):1189-93. PubMed ID: 16622902
[TBL] [Abstract][Full Text] [Related]
14. Detection and monitoring of methotrexate-associated lung injury using serum markers KL-6 and SP-D in rheumatoid arthritis.
Miyata M; Sakuma F; Fukaya E; Kobayashi H; Rai T; Saito H; Kasukawa R; Suzuki S
Intern Med; 2002 Jun; 41(6):467-73. PubMed ID: 12135181
[TBL] [Abstract][Full Text] [Related]
15. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.
Shidara K; Hoshi D; Inoue E; Yamada T; Nakajima A; Taniguchi A; Hara M; Momohara S; Kamatani N; Yamanaka H
Mod Rheumatol; 2010 Jun; 20(3):280-6. PubMed ID: 20217173
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
Salaffi F; Manganelli P; Carotti M; Subiaco S; Lamanna G; Cervini C
Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
[TBL] [Abstract][Full Text] [Related]
17. Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept.
Mochizuki T; Ikari K; Yano K; Sato M; Okazaki K
Mod Rheumatol; 2019 May; 29(3):413-417. PubMed ID: 29798700
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
19. Clinical expression of leflunomide-induced pneumonitis.
Chikura B; Lane S; Dawson JK
Rheumatology (Oxford); 2009 Sep; 48(9):1065-8. PubMed ID: 19321511
[TBL] [Abstract][Full Text] [Related]
20. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis.
Golden MR; Katz RS; Balk RA; Golden HE
J Rheumatol; 1995 Jun; 22(6):1043-7. PubMed ID: 7674228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
